Anti-CD137抗体,肿瘤坏死因子受体超家族成员9抗体,免疫沉淀抗体 来源:Rabbit 克隆类型:Polyclonal浓度:1mg/ml亚型:IgG应用: WB=1:1000 ELISA=1:1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 IP=1:100 Flow-Cyt=1:100-200反应: Human 免疫原:KLH conjugated synthetic peptide derived from CD13...
英文名称 Anti-CD137 价格说明 价格:商品在爱采购的展示标价,具体的成交价格可能因商品参加活动等情况发生变化,也可能随着购买数量不同或所选规格不同而发生变化,如用户与商家线下达成协议,以线下协议的结算价格为准,如用户在爱采购上完成线上购买,则最终以订单结算页价格为准。 抢购价:商品参与营销活动的活动价...
英文别名: ANTI-4-1BB;ANTI-CD137;ANTI-HUMAN CD137;ANTI-HUMAN 4-1BB;ANTI-CD137 (HUMAN);ANTI-4-1BB (HUMAN);ANTI-TNFRSF 9 (HUMAN);ANTI-CD137 (4-1BB), HUMAN;ANTI-HUMAN CDW137 (4-1BB);ANTI-4-1BB (140-155), MOUSE (RABBIT)中文名: ANTI-CD137 ...
anti-CD137 (human), mAb (4B4-1)白细胞分化抗原137 (人), 单克隆抗体 (4B4-1) 价格￥3500 起批量≥1盒 最小起订1盒 供货总量200盒 发货地址江苏省南京市 建议售价￥3500/盒 更新日期2024年08月30日 产品规格100 μg 洽谈立即询价查看联系方式 ...
Anti-CD137 antibody 英文名称: Anti-CD137 antibody 总访问: 105 国产/进口: 国产 半年访问: 20 产地/品牌: FineTest 产品类别: 抗体 规格: 20μg, 50μg, 100μg 最后更新: 2024-11-4 货号: FNab10476 CAS 号: 参考报价: 询价 立即询价 电话咨询 ...
Anti CD137 antibodyThe present invention relates to antibodies that bind to human CD137, exhibit agonist activity, and can be useful in treating solid tumors and blood tumors alone and in combination with chemotherapy and ionizing radiation. No selectionクリストファーカールフライ...
ANTI-CD137 Product NameANTI-CD137 CAS MF MW0 EINECS MOL FileMol File Chemical Properties storage temp.−20°C formlyophilized powder MSDS Usage And Synthesis ANTI-CD137 Supplier
Disclosed herein are agonistic anti-CD137 antibodies and methods of using such for eliciting CD137 signaling, thereby enhancing immune responses such as T cell functions. The antibodies disclosed within may be used to treat diseases, such as cancer and immune disorders. 二、法律状态 暂无信息 三、...
ANTI-CD137 Basic information More.. Product Name: ANTI-CD137 Synonyms: ANTI-HUMAN 4-1BB;ANTI-HUMAN CD137;ANTI-HUMAN CDW137 (4-1BB);ANTI-TNFRSF 9 (HUMAN);ANTI-4-1BB (140-155), MOUSE (RABBIT);ANTI-4-1BB;ANTI-4-1BB (HUMAN);ANTI-CD137 CAS: MF: MW: 0 EINECS: Mol File...
Anti-CD137 immunotherapy for autoimmune diseases?Anti-CD137-ligand-monoclonal-antibody, pharmacodynResearch-and-developmentInpharma Weekly -doi:10.2165/00128413-200313730-00018NoneSpringer International PublishingInpharma Weekly